Ramon C Hermida

Summary

Affiliation: University of Vigo
Country: Spain

Publications

  1. Hermida R, Ayala D, Smolensky M, Fernandez J, Mojon A, Portaluppi F. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Med Rev. 2017;33:17-27 pubmed publisher
    ..e., those diagnosed with chronic kidney disease, diabetes, and resistant hypertension. ..
  2. Hermida R, Ayala D, Khder Y, Calvo C. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial. Clin Ther. 2008;30:108-20 pubmed publisher
    ..There was no significant change in the efficacy of valsartan in the 24 hours after a missed dose. At the doses tested, valsartan was more effective than enalapril, both during active treatment and after a missed dose. ..
  3. Hermida R, Ayala D, Mojon A, Fontao M, Fernandez J. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 2011;28:601-10 pubmed publisher
    ....
  4. Hermida R, Ayala D, Mojon A, Fernandez J. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox. Chronobiol Int. 2013;30:87-98 pubmed publisher
    ..Our findings also indicate the need to redefine the concepts of normotension/hypertension, so far established on the unique basis of BP level, mainly if not exclusively measured at the clinic, independently of circadian BP pattern. ..
  5. Hermida R, Ayala D, Smolensky M, Mojon A, Fernandez J, Crespo J, et al. Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol. 2013;9:358-68 pubmed publisher
    ....
  6. Hermida R, Ayala D, Mojon A, Fernandez J. Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD. J Am Soc Nephrol. 2017;28:2802-2811 pubmed publisher
    ..Furthermore, progressive treatment-induced decrease of asleep BP, a potential therapeutic target requiring ambulatory BP evaluation, might be a significant method for reducing CKD risk. ..
  7. Hermida R, Ayala D, Fernandez J, Mojon A, Crespo J, Ríos M, et al. Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management. Heart Fail Clin. 2017;13:759-773 pubmed publisher
    ..Ingestion time, according to circadian rhythms, of hypertension medications of 6 different classes and their combinations significantly improves BP control, particularly sleep-time BP, and reduces adverse effects. ..

Detail Information

Publications7

  1. Hermida R, Ayala D, Smolensky M, Fernandez J, Mojon A, Portaluppi F. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Med Rev. 2017;33:17-27 pubmed publisher
    ..e., those diagnosed with chronic kidney disease, diabetes, and resistant hypertension. ..
  2. Hermida R, Ayala D, Khder Y, Calvo C. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial. Clin Ther. 2008;30:108-20 pubmed publisher
    ..There was no significant change in the efficacy of valsartan in the 24 hours after a missed dose. At the doses tested, valsartan was more effective than enalapril, both during active treatment and after a missed dose. ..
  3. Hermida R, Ayala D, Mojon A, Fontao M, Fernandez J. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 2011;28:601-10 pubmed publisher
    ....
  4. Hermida R, Ayala D, Mojon A, Fernandez J. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox. Chronobiol Int. 2013;30:87-98 pubmed publisher
    ..Our findings also indicate the need to redefine the concepts of normotension/hypertension, so far established on the unique basis of BP level, mainly if not exclusively measured at the clinic, independently of circadian BP pattern. ..
  5. Hermida R, Ayala D, Smolensky M, Mojon A, Fernandez J, Crespo J, et al. Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol. 2013;9:358-68 pubmed publisher
    ....
  6. Hermida R, Ayala D, Mojon A, Fernandez J. Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD. J Am Soc Nephrol. 2017;28:2802-2811 pubmed publisher
    ..Furthermore, progressive treatment-induced decrease of asleep BP, a potential therapeutic target requiring ambulatory BP evaluation, might be a significant method for reducing CKD risk. ..
  7. Hermida R, Ayala D, Fernandez J, Mojon A, Crespo J, Ríos M, et al. Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management. Heart Fail Clin. 2017;13:759-773 pubmed publisher
    ..Ingestion time, according to circadian rhythms, of hypertension medications of 6 different classes and their combinations significantly improves BP control, particularly sleep-time BP, and reduces adverse effects. ..